Medroxyprogesterone Acetate

This is a specific form of the hormone medicine mentioned above. It's often used as a birth control method in women, either taken by mouth or injected into a muscle. It can also be used to treat certain types of breast or uterine cancer.

Brand names:Cycrin, Depo-Provera, Provera
Medication

What people taking Medroxyprogesterone Acetate report

Every report comes from a Lived member, sent anonymously.

Have you tried Medroxyprogesterone Acetate for Menopause?

NameHow it went

About Medroxyprogesterone Acetate

What It's For

Medroxyprogesterone acetate is a man-made version of progesterone, the hormone that matures the lining of the uterus each cycle and supports early pregnancy. Medicines in this group are called progestins. The same drug comes in two forms that do quite different jobs. As an injection, it is a long-acting birth control method often called the shot or DMPA (depot medroxyprogesterone acetate). Depo-Provera CI is injected into a muscle, and depo-subQ provera 104 is a lower-dose version injected under the skin. Depo-subQ provera 104 is also approved to treat pain from endometriosis, a condition in which tissue similar to the uterine lining grows outside the uterus. As a tablet, sold as Provera and as a generic, it is used to bring on a period when periods have stopped for reasons other than pregnancy or menopause, to treat abnormal uterine bleeding caused by a hormone imbalance rather than a structural problem such as fibroids, and to protect the uterine lining in postmenopausal women who still have a uterus and take estrogen. At usual doses the tablets do not prevent ovulation and are not birth control. Prempro and Premphase combine medroxyprogesterone with estrogen as menopausal hormone therapy; Cycrin is a former tablet brand that is no longer sold.

How It Works

Progesterone's natural role is to switch the uterine lining from a growing phase to a stable, mature one. When progesterone levels fall at the end of a cycle, the lining sheds as a period. Medroxyprogesterone copies that signal. At the high, steady levels the injection produces, it also tells the brain to cut back on the hormones (gonadotropins) that prompt an ovary to mature and release an egg. Without ovulation there is no egg to fertilize. It also thickens the mucus at the cervix, which makes it harder for sperm to get through. Because the ovaries then make less estrogen, bone can gradually lose density, which is the reason for the injection's main warning. The tablets act on the uterine lining rather than on ovulation. A short course mimics the second half of a cycle, and stopping it triggers a withdrawal bleed. Taken alongside estrogen after menopause, it keeps estrogen from overstimulating the lining, which would otherwise raise the risk of endometrial (uterine) cancer.

Dosage & Administration

The contraceptive injection is given every 3 months. Depo-Provera CI is a 150 mg shot into the buttock or upper arm muscle every 13 weeks. Depo-subQ provera 104 is a 104 mg shot under the skin of the thigh or abdomen every 12 to 14 weeks. Its label calls for a clinician to give it, although guidance from the Centers for Disease Control and Prevention (CDC) supports offering self-injection at home and some clinics do. If the first shot is given within 7 days after a period starts, no back-up is needed; otherwise, use condoms or avoid sex for the next 7 days. Protection depends on staying on schedule. Under CDC guidance, a repeat shot can be given up to 2 weeks late (15 weeks after the last one) without back-up. Beyond that, the clinician confirms you are not pregnant before giving it, and back-up contraception is needed for 7 days. If you had sex while overdue, ask whether emergency contraception makes sense. Tablets are usually taken once a day for a set number of days: often 5 to 10 days to bring on a period, or 12 to 14 days each month alongside daily estrogen after menopause. Some menopausal regimens, such as Prempro, instead combine a lower daily dose with estrogen every day. A withdrawal bleed usually starts 3 to 7 days after the last tablet of a short course. The prescriber sets the dose and which days of the cycle to take it.

Side Effects

Changes in bleeding are the most common effect of the injection. In the first months, many people have irregular, unpredictable spotting or bleeding, and some have prolonged or heavy bleeding. With continued use, bleeding tends to settle and periods often stop altogether: in clinical studies, about half of users had no periods at one year and about two-thirds at two years. Having no periods on the shot is not harmful, but heavy or persistent bleeding is worth having checked. Weight gain is also common. In studies, users gained an average of about 5 pounds in the first year and about 8 pounds over two years, and some gained considerably more. Headache, abdominal discomfort, nervousness, dizziness and lower sex drive are other frequently reported effects. A sore spot, lump or dimple in the skin can occur where the shot was given. Short courses of tablets more often cause breast tenderness, spotting or changes in menstrual flow, nausea, headache, sleep changes and fluid retention. Serious reactions are uncommon, and each warning sign points to a specific problem. Contact the prescriber right away for severe lower abdominal pain, which can signal a pregnancy growing outside the uterus (ectopic pregnancy) if the shot has failed; severe pain or swelling in one calf, a possible blood clot in the leg; yellowing of the skin or eyes, a possible liver problem; or depression that returns or worsens. Call 911 for signs of a blood clot in the lung (chest pain, coughing up blood or sudden shortness of breath), a stroke (a sudden severe headache, sudden weakness or numbness in an arm or leg, or sudden trouble speaking or seeing), or a severe allergic reaction (swelling of the face, tongue or throat).

Interactions & Warnings

The injection carries the Food and Drug Administration's (FDA's) strongest label warning, a boxed warning, about bone loss. Bone density falls during use, the loss grows the longer the shot is used, and it may not fully recover after stopping. This matters most for teenagers and young adults, who are still building bone. For that reason the shot is not recommended for more than 2 years unless other methods are unsuitable. People with other risks for thin bones, such as heavy alcohol or tobacco use, anorexia nervosa, a strong family history of osteoporosis, or long-term steroid or seizure medicines, should weigh this carefully. Getting enough calcium and vitamin D is commonly advised. Medroxyprogesterone is not used by people who have or have had blood clots or a stroke, have breast cancer, have significant liver disease, or have unexplained vaginal bleeding. The injection label also describes a possible small increase in breast cancer risk among recent users who used the shot for a year or more. Meningioma, a usually noncancerous tumor of the membranes around the brain, has been reported mainly with long-term use, and anyone who has had one should raise it before starting. Some medicines speed up the breakdown of contraceptive hormones and may make the shot less reliable. Examples include the seizure medicines carbamazepine, phenytoin and topiramate, the tuberculosis antibiotic rifampin, and the herbal supplement St. John's wort. The injection label advises a back-up or different method, although CDC contraceptive guidance treats the shot as less affected by these medicines than birth control pills, so ask the prescriber whether this applies to you. The shot does not protect against HIV or other sexually transmitted infections. The tablets carry a different boxed warning that applies when they are combined with estrogen after menopause. In the large Women's Health Initiative trial, estrogen plus medroxyprogesterone increased the risk of breast cancer, blood clots, stroke and heart attack, and of probable dementia in women 65 and older. The combination should not be used to prevent heart disease or dementia, and it is prescribed at the lowest effective dose for the shortest time that meets treatment goals. The tablets should not be taken during pregnancy.

What to Expect

With the injection, protection lasts as long as shots stay on schedule, and there is nothing to remember day to day. In real-world use, including late shots, about 4 in 100 users become pregnant in the first year. Bleeding is often unpredictable at first and, for many people, becomes lighter or stops over the first year. A yearly visit typically includes a blood pressure check, and people with diabetes may need closer blood sugar monitoring because the shot can reduce how well the body handles glucose. If use is heading past 2 years, the clinician will revisit whether to continue and may check bone density. Fertility does not return right away after the last shot. In the main US study, people who stopped in order to become pregnant took a median of about 10 months to conceive, with a range of 4 to 31 months, regardless of how long they had used it. That makes the shot a poor fit for someone hoping to become pregnant soon. Tablets used to bring on a period are a short course, and a bleed usually follows within a week of the last pill. Tablets taken with estrogen after menopause continue as long as estrogen does, with periodic review, often every 3 to 6 months, of whether treatment is still needed.

Questions to Ask Your Doctor

  1. 1.Is the shot, the tablets or a different option the best fit for what I need, and why?
  2. 2.Given my age and bone health, how long should I use the injection, and would I need a bone density test?
  3. 3.What should I do if I can't get my next shot on time, and should I keep condoms or emergency contraception on hand?
  4. 4.How long might it take to get pregnant after I stop, and when should I stop if I'm planning a pregnancy?
  5. 5.Do any of my medicines or supplements, or a history of clots, depression or migraines, change whether this is safe for me?

Last reviewed • Oct 2026

Educational content, not medical advice.